| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/19/2004 | US20040033216 Harvesting the pancreas of piglets at or near full term gestation, and extracting pancreatic beta islet cells exposed to nicotinamide |
| 02/19/2004 | US20040033215 Transferring a cell proliferation factor gene into a mammalian liver cell, for an in vitro immortalized cell, proliferating the immortalized cell, and removing the cell proliferation factor gene |
| 02/19/2004 | US20040033214 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 02/19/2004 | US20040033212 Isolated population of superficial zone chondroprogenitor cells; replacement of damaged cartilage |
| 02/19/2004 | US20040031447 Animal papilla disinfectants and method of improving microbial environment |
| 02/19/2004 | DE4392789B4 Verfahren zur Gewinnung von Blutkomponenten aus Übergangszonenmaterial Process for the recovery of blood components from transition zone material |
| 02/19/2004 | CA2818693A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2759572A1 Isolation and identification of t cells |
| 02/19/2004 | CA2496002A1 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | CA2495112A1 Mechanisms of myoblast transfer in treating heart failure |
| 02/19/2004 | CA2494844A1 Methods and compositions concerning poxviruses and cancer |
| 02/19/2004 | CA2494675A1 Immunomodulating compositions, processes for their production and uses therefor |
| 02/19/2004 | CA2489301A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/18/2004 | EP1389466A1 Immunopotentiators |
| 02/18/2004 | EP1389464A1 Compositions containing bacterium capable of converting lactic acid into butyric acid and method of preventing/treating hyperlactic acidemia in digestive tract and colon cancer by using the same |
| 02/18/2004 | EP1389234A2 Cd8alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation |
| 02/18/2004 | EP1389133A1 Methods for inactivating viruses |
| 02/18/2004 | EP1389130A2 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 02/18/2004 | EP1389111A1 COMPOSITION FOR INHIBITING HIV ACTIVITY EXTRACTED FROM i PAECILOMYCES SP. /i (TOCHU-KASO) J300 |
| 02/18/2004 | EP1389043A1 Foot and mouth disease virus vaccine |
| 02/18/2004 | EP1178822B1 Whole cell cancer vaccine comprising co-cultured malignant and non-malignant cells |
| 02/18/2004 | EP1123314B1 Use of a cytokine-producing lactococcus strain to treat colitis |
| 02/18/2004 | EP0948337B1 Treatment of hemoglobin containing erythrocytes with nitric oxide |
| 02/18/2004 | CN1475557A Formulating method of deer blood wine |
| 02/18/2004 | CN1475266A Production method of injection agent used for treating cardio and cerebro vascular diseases and its product |
| 02/18/2004 | CN1475252A Medicine for treating osteoporosis and its preparation method |
| 02/18/2004 | CN1475234A Medicinal composition for treating cancer |
| 02/18/2004 | CN1475227A Composition for preventing and treating climacteric sgndrome, osteoporosis and mastocancer |
| 02/18/2004 | CN1138771C 6-hydroxy-3-(4-[2-piperidine-1-group) oxyethyl group] phenoxy)-2-(4-methoxyphenyl) benzo[b] thiophene hydrochloride salt |
| 02/18/2004 | CN1138564C Influenza vaccine |
| 02/18/2004 | CN1138560C Method for control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 02/18/2004 | CN1138559C Pill medicine for treating cardio-cerebro vascular diseases |
| 02/18/2004 | CN1138554C Traditional Chinse medicine compounded preparation for preventing and treating rabies and preparation method thereof |
| 02/18/2004 | CN1138551C Eipthelial adhesive lactobacilli |
| 02/18/2004 | CN1138550C Process of producing extracts of shark |
| 02/18/2004 | CN1138549C Mampalon perfume and its producing method |
| 02/17/2004 | US6692958 Cord blood-derived activated lymphocytes, preparations containing said lymphocytes as main ingredient and method and kit for producing said preparations |
| 02/17/2004 | US6692956 Recombinant adenoviral vectors |
| 02/17/2004 | US6692750 Introducing into cells recombinant alphavirus rna genome and helper rna encoding alphavirus structural proteins, including coding sequences for proteins and cis acting replication signals; incubating to produce infectious virus particles |
| 02/17/2004 | US6692746 Tumor killing effects of enterotoxins, superantigens, and related compounds |
| 02/17/2004 | US6692738 Implanting cell-matrix structure comprising matrix having attached thereto an effective amount of cells stably expressing a gene encoding biological modifier to stop or regress the excessive tissue proliferation |
| 02/13/2004 | CA2437064A1 Storage-stable, liquid fibrinogen formulation |
| 02/12/2004 | WO2004013343A2 Use of lactobacillus to produce exopolysaccharides in food and pharmaceutical compositions |
| 02/12/2004 | WO2004013317A1 A method of obtaining a bacteriophage strain of increased affinity to eukaryotic cells, preparations containing it, and applications of bacteriophages |
| 02/12/2004 | WO2004013310A2 Methods of down regulating target gene expression in vivo by introduction of interfering rna |
| 02/12/2004 | WO2004013275A2 Stem cells derived from adipous tissue and differentiated cells derived from said cells |
| 02/12/2004 | WO2004012791A2 Improved injection system |
| 02/12/2004 | WO2004012768A1 Tolerance induction with help of a combination of a lfa-1 inhibitor and a costimulation inhibitor and/or a mtor inhibitor |
| 02/12/2004 | WO2004012751A1 Bacterial cell wall skeleton component preparaion |
| 02/12/2004 | WO2004012750A1 Method of preparing platelet rich plasma |
| 02/12/2004 | WO2004012503A2 Compositions comprising muscle progenitor cells and uses thereof |
| 02/12/2004 | WO2003093462A3 Immobilisation and stabilisation of virus |
| 02/12/2004 | WO2003092474A3 Vascularization enhanced graft constructs |
| 02/12/2004 | WO2003072789A3 Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors |
| 02/12/2004 | WO2003070171A9 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 02/12/2004 | WO2003065994A3 Schwann cell and phosphodiesterase inhibitors based therapy |
| 02/12/2004 | WO2003065979A3 Methods of diagnosis, monitoring and treatment of fertility |
| 02/12/2004 | WO2003059264A3 Methods for the induction of professional and cytokine-producing regulatory cells |
| 02/12/2004 | WO2003050502A3 Prospective identification and characterization of breast cancer stem cells |
| 02/12/2004 | WO2003050250A3 Chondrocyte precursors derived from human embryonic stem cells |
| 02/12/2004 | WO2003050249A3 Islet cells from human embryonic stem cells |
| 02/12/2004 | WO2003046161A3 Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells |
| 02/12/2004 | WO2003045226A3 Eb matrix production from animal tissue and its use for tissue repair |
| 02/12/2004 | WO2003035012A3 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 02/12/2004 | WO2003033686A3 Keratinocytes which may be used as biologically active substances for the treatment of wounds |
| 02/12/2004 | WO2002095010A3 Human secreted proteins |
| 02/12/2004 | WO2002067863A3 Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 02/12/2004 | US20040031067 Compositions and methods for preparing vascularized dermal reconstructs, vascularized skin grafts, and for enhancing vascularization in situ in response to a variety of medical conditions |
| 02/12/2004 | US20040030406 Tissue equivalent for transplantation and process for producing the same |
| 02/12/2004 | US20040030404 Method for cultivating a cartilage replacement and a biomatrix produced according to this method |
| 02/12/2004 | US20040030403 Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair |
| 02/12/2004 | US20040029829 Bean extract; fermentation |
| 02/12/2004 | US20040029786 Treatment of ulcerative colitis by introducing CEP antigen composition |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040029280 Viral vectors with modified tropism |
| 02/12/2004 | US20040029279 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 02/12/2004 | US20040029271 Pax5-deficient pro-B cells, methods of producing them and the use of such cells in human therapy |
| 02/12/2004 | US20040029250 Method and device for sanitation using bacteriophages |
| 02/12/2004 | US20040029127 Use of lactobacillus case in immunostimulatory peptides |
| 02/12/2004 | US20040029112 Oncolytic viruses as phenotyping agents for neoplasms |
| 02/12/2004 | US20040029106 Duplexed parvovirus vectors |
| 02/12/2004 | US20040028748 Remedies for dermatophytosis |
| 02/12/2004 | US20040028731 Active materials in pellet; veterinary medicine; fungicides, nematocides, parasiticides |
| 02/12/2004 | US20040028712 Cosmetics for topical applying; plant extracts |
| 02/12/2004 | US20040028700 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 02/12/2004 | US20040028696 Kefir as a potent anti-oxidant composition |
| 02/12/2004 | US20040028693 Fusion protein viricides |
| 02/12/2004 | US20040028692 Sensitization process for antigen-presenting cells and means for implementing the process |
| 02/12/2004 | US20040028689 Gastrointestinal diosrders |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028677 Chimeric allograft tolerance induction, monitoring and maintenance |
| 02/12/2004 | US20040028665 Compositions and methods for inhibiting pathogenic growth |
| 02/12/2004 | US20040028660 Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative disorders and myelodysplastic syndromes |
| 02/12/2004 | US20040028658 Methods of organ regeneration |
| 02/12/2004 | US20040028656 Survival of neurons |
| 02/12/2004 | US20040028653 Self-rearranging DNA vectors |
| 02/12/2004 | US20040028649 Regenerating cells |
| 02/12/2004 | DE20315960U1 Knorpelersatzimplantat Cartilage replacement implant |